DNA Methylation Profiles of PSMA6, PSMB5, KEAP1, and HIF1A Genes in Patients with Type 1 Diabetes and Diabetic Retinopathy

Zane Svikle,Natalia Paramonova,Emīls Siliņš,Leonora Pahirko,Līga Zariņa,Kristīne Baumane,Goran Petrovski,Jelizaveta Sokolovska
DOI: https://doi.org/10.3390/biomedicines12061354
IF: 4.757
2024-06-19
Biomedicines
Abstract:We explored differences in the DNA methylation statuses of PSMA6, PSMB5, HIF1A, and KEAP1 gene promoter regions in patients with type 1 diabetes and different diabetic retinopathy (DR) stages. Study subjects included individuals with no DR (NDR, n = 41), those with non-proliferative DR (NPDR, n = 27), and individuals with proliferative DR or those who underwent laser photocoagulation (PDR/LPC, n = 46). DNA methylation was determined by Zymo OneStep qMethyl technique. The methylation of PSMA6 (NDR 5.9 (3.9–8.7) %, NPDR 4.5 (3.8–5.7) %, PDR/LPC 6.6 (4.7–10.7) %, p = 0.003) and PSMB5 (NDR 2.2 (1.9–3.7) %, NPDR 2.2 (1.9–3.0) %, PDR/LPC 3.2 (2.5–7.1) %, p < 0.01) differed across the groups. Consistent correlations were observed between the methylation levels of HIF1A and PSMA6 in all study groups. DNA methylation levels of PSMA6, PSMB5, and HIF1A genes were positively correlated with the duration of diabetes, HbA1c, and albuminuria in certain study groups. Univariate regression models revealed a significant association between the methylation level z-scores of PSMA6, PSMB5, and HIF1A and severe DR (PSMA6: OR = 1.96 (1.15; 3.33), p = 0.013; PSMB5: OR = 1.90 (1.14; 3.16), p = 0.013; HIF1A: OR = 3.19 (1.26; 8.06), p = 0.014). PSMB5 remained significantly associated with DR in multivariate analysis. Our findings suggest significant associations between the severity of DR and the DNA methylation levels of the genes PSMA6, PSMB5, and HIF1A, but not KEAP1 gene.
biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the differences in DNA methylation status in the promoter regions of PSMA6, PSMB5, HIF1A and KEAP1 genes at different diabetic retinopathy (DR) stages in patients with type 1 diabetes. Specifically, the study aims to: 1. **Compare the DNA methylation levels of patients with different DR severities**: By analyzing patients without retinopathy (NDR), non - proliferative retinopathy (NPDR) and proliferative retinopathy or those who have received laser photocoagulation treatment (PDR/LPC), study whether there are significant differences in the methylation levels of these genes at different DR stages. 2. **Explore the relationship between DNA methylation and clinical parameters**: Evaluate the correlation between the methylation levels of these genes and clinical parameters such as diabetes duration, glycated hemoglobin (HbA1c), and albuminuria. 3. **Evaluate the association between DNA methylation levels and severe DR**: Use a logistic regression model to analyze whether the methylation levels of these genes are associated with the occurrence of severe DR. ### Main findings: - **There are significant differences in the methylation levels of PSMA6 and PSMB5 genes among different DR groups**: The methylation level of the PSMA6 gene in the PDR/LPC group is significantly higher than that in the NDR and NPDR groups (p = 0.003), and the methylation level of the PSMB5 gene in the PDR/LPC group is also significantly higher than that in the NDR and NPDR groups (p < 0.01). - **The methylation level of the HIF1A gene is positively correlated with that of the PSMA6 gene in all study groups**. - **There is a correlation between DNA methylation levels and clinical parameters such as diabetes duration, HbA1c and albuminuria**: For example, in the NDR group, the methylation levels of the HIF1A and PSMA6 genes are positively correlated with diabetes duration. - **Logistic regression analysis shows that the methylation levels of PSMA6, PSMB5 and HIF1A genes are significantly associated with the occurrence of severe DR**: In particular, in multivariate analysis, the methylation level of the PSMB5 gene is still significantly associated with severe DR after adjusting for age, sex, smoking and hypertension (OR = 1.57, 95% CI: 1.04; 2.36, p = 0.030). ### Conclusion: The research results show that the DNA methylation levels of PSMA6, PSMB5 and HIF1A genes are significantly associated with the DR severity in patients with type 1 diabetes, while the methylation level of the KEAP1 gene does not show a significant association. These findings provide new insights into understanding the epigenetic mechanisms of DR and may provide potential biomarkers for future diagnosis and treatment.